Picture of Xilio Therapeutics logo

XLO — Xilio Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapTurnaround

Brief: Merck & Co., Inc. Says Has 5.4% Passive Stake In Xilio Therapeutics, Inc. As Of March 30, 2023 - SEC Filing

April 10 (Reuters) - Merck & Co Inc  MRK.N :
    * MERCK & CO., INC. SAYS HAS 5.4% PASSIVE STAKE IN XILIO
THERAPEUTICS, INC. AS OF MARCH 30, 2023 - SEC FILING

Source text for Eikon:  ID: 
Further company coverage:  MRK.N 

 ((Reuters.Brief@thomsonreuters.com;))

Recent news on Xilio Therapeutics

See all news